HF Advisory Group, LLC

Position in GSK — GSK plc

CIK 1963169 Annapolis, MD

Position in GSK

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$397,238

-$6,697 QoQ

Shares Held

7,578

+3.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#529

of 1,033 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HF Advisory Group, LLC holds $13,388,647 across 8 Drug Manufacturers - General names. GSK ranks #8 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	23,463	$2,964,315
2	LLY	ELI LILLY & Co	2,246	$2,693,920
3	PFE	Pfizer Inc	102,378	$2,465,262
4	SNY	Sanofi	37,289	$1,590,748
5	NVS	Novartis AG	8,551	$1,340,112
6	JNJ	Johnson & Johnson	4,322	$1,097,658
7	AMGN	Amgen Inc	2,318	$839,394
8	GSK	GSK plc This page	7,578	$397,238

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$397,238	7,578	+3.5%	Shares	Sole	2026-07-09
2026-03-31	$403,935	7,319	-15.3%	Shares	Sole	2026-04-21
2025-12-31	$423,999	8,646	-9.5%	Shares	Sole	2026-01-23
2025-09-30	$412,523	9,558	+2.2%	Shares	Sole	2025-10-06
2025-06-30	$359,193	9,354	-4.1%	Shares	Sole	2025-07-10
2025-03-31	$377,908	9,755	+11.6%	Shares	Sole	2025-04-10
2024-12-31	$295,688	8,743	+12.8%	Shares	Sole	2025-01-15
2024-09-30	$316,942	7,753	-8.5%	Shares	Sole	2024-10-30
2024-06-30	$326,095	8,470	+5.0%	Shares	Sole	2024-07-18
2024-03-31	$345,746	8,065	-5.4%	Shares	Sole	2024-04-22
2023-12-31	$316,010	8,527	-2.1%	Shares	Sole	2024-01-31
2023-09-30	$315,592	8,706	+2.4%	Shares	Sole	2023-10-31
2023-06-30	$303,118	8,505	+4.5%	Shares	Sole	2023-07-20
2023-03-31	$289,478	8,136	+9.0%	Shares	Sole	2023-04-19
2022-12-31	$262,214	7,462	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.